CASP3 and cancer: MCL1 is known to disrupt BAK/BAX/caspase-3,7–dependent apoptosis, and pharmacological inhibition by AZD5991/S63845 inhibits the binding of BAK and BAX to MCL1, resulting in cancer cell death (24, 25).